The Latest
-
Cara Therapeutics'(NASDAQ:CARA) Share Price Is Down 31% Over The Past Year.
-
Wells Fargo swings to $2.4 billion loss as pandemic bites
-
Wells Fargo CEO: ‘The length and severity of the economic downturn has deteriorated considerably’
-
Canada’s Medicago begins human trials of plant-based COVID-19 vaccine